AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 90 filers reported holding AVROBIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $376,000 | -33.1% | 97,597 | -3.1% | 0.01% | -38.5% |
| Q3 2021 | $562,000 | -36.4% | 100,705 | +1.3% | 0.01% | -31.6% |
| Q2 2021 | $884,000 | -32.8% | 99,413 | -4.0% | 0.02% | -26.9% |
| Q1 2021 | $1,315,000 | -48.7% | 103,591 | -43.7% | 0.03% | -55.2% |
| Q4 2020 | $2,565,000 | +56.2% | 184,001 | +45.9% | 0.06% | +23.4% |
| Q3 2020 | $1,642,000 | -26.5% | 126,103 | -1.5% | 0.05% | -27.7% |
| Q2 2020 | $2,234,000 | +17.4% | 128,018 | +4.7% | 0.06% | -7.1% |
| Q1 2020 | $1,903,000 | -42.3% | 122,310 | -25.3% | 0.07% | -13.6% |
| Q4 2019 | $3,296,000 | – | 163,745 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |